Ablative Radiotherapy for Patients With Inoperable Pancreas Cancer-Ready for Prime Time?

David P Horowitz^{1

2}, Karyn Goodman³, Lisa A Kachnic^{1

2}

Affiliations

¹ Department of Radiation Oncology, Columbia University Irving Medical Center, New York, New York.
² Columbia University Herbert Irving Comprehensive Cancer Center, New York, New York.
³ Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.

Editorial

David P Horowitz et al. JAMA Oncol. 2021.

. 2021 May 1;7(5):687-688.

doi: 10.1001/jamaoncol.2021.0028.

David P Horowitz^{1

2}, Karyn Goodman³, Lisa A Kachnic^{1

2}

¹ Department of Radiation Oncology, Columbia University Irving Medical Center, New York, New York.
² Columbia University Herbert Irving Comprehensive Cancer Center, New York, New York.
³ Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

Comment on

Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer.
Reyngold M, O'Reilly EM, Varghese AM, Fiasconaro M, Zinovoy M, Romesser PB, Wu A, Hajj C, Cuaron JJ, Tuli R, Hilal L, Khalil D, Park W, Yorke ED, Zhang Z, Yu KH, Crane CH. Reyngold M, et al. JAMA Oncol. 2021 May 1;7(5):735-738. doi: 10.1001/jamaoncol.2021.0057. JAMA Oncol. 2021. PMID: 33704353 Free PMC article.